NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
July 5, 2005 • Volume 2 / Number 27 E-Mail This Document  |  View PDF Version  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Virus Selectively Kills Cancer Cells, Study Indicates

Director's Update
Strengthening the Evidence Base for Quality Cancer Care

Spotlight
Complementary and Alternative Medicine: Expanding Approaches to Cancer Treatment

Cancer Research Highlights
PLCO Publishes Sigmoidoscopy Results

Women's Health Study Finds No Anticancer Benefit of Aspirin and Vitamin E

"Freckling" Gene Associated with Melanoma Risk in Italian Population

During Pregnancy, Chemotherapy for Breast Cancer Is Safe

Adjuvant Capecitabine Effective Against Colon Cancer

Incidence of Inflammatory Breast Cancer May Be Rising, Study Suggests

Featured Clinical Trial
Chemotherapy and Biological Therapy for Advanced Mesothelioma

Notes
NCI Staff Present at PACHA Meeting

Tomaszewski Named Deputy Director of DCTD

Retiring BSA Members Honored

Special Issue on Cancer Communications

Community Update
Cancer.gov Unveils New User-Friendly Drug Dictionary

Bulletin Archive

Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
Community Update Community Update

Cancer.gov Unveils New User-Friendly Drug Dictionary

Featured Meetings and Events
A calendar of scientific meetings and events sponsored by the National Institutes of Health is available at: http://calendar.nih.gov/
cgi-bin/calendar/
The latest enhancement to NCI's award-winning Web site is the NCI Drug Dictionary (www.cancer.gov/drugdictionary). Approximately 500 drugs and biologic agents currently being used in cancer clinical trials are listed in the dictionary. The dictionary will soon grow to include additional categories of drugs and agents.

The NCI Drug Dictionary provides brief, accurate descriptions of cancer-related drugs and biologic agents, including information about chemical class and mechanism of action. "Although this dictionary is designed for health professionals, we hope that others who are either involved in or have an interest in cancer therapeutics, including patients, will find it useful," said Dr. Richard Manrow, associate director of the Office of Cancer Content Management in NCI's Office of Communications. Dr. Manrow also commented that NCI's Office of Communications plans to greatly expand the amount of drug information for lay readers on NCI's Web site. "Drugs as a category are second only to types of cancer in searches performed on NCI's Web site," Dr. Manrow said.

A link to the NCI Drug Dictionary is located in the Quick Links box on the left side of most Web pages on www.cancer.gov, as well as on drug information pages.

The NCI Drug Dictionary contains several useful features:

  • Flexible search options - In addition to a standard "starts with" search option, users can also enter only a part of a word or term, and use a "contains" option. Users can also search by generic name, brand name, chemical structure name, FDA Investigational New Drug name, or Cancer Chemotherapy National Service Center number, which is NCI's internal drug identification number.
  • Browsing functionality - Users who want to browse the dictionary can select a letter of the alphabet and browse drug or agent names (generic and U.S. brand names) that begin with that letter.
  • Links to clinical trials - Many drug entries in the dictionary include links to current clinical trials listed in NCI's Physician Data Query (PDQ®) cancer clinical trials registry in which those drugs are being used. This cross-indexing of NCI Drug Dictionary and PDQ clinical trial entries will become much more comprehensive in the future.

Each entry in the NCI Drug Dictionary draws on and provides a link to more detailed information available in the NCI Thesaurus™, which also contains information on relationships to specific cancers, molecular targets, and other drugs, as well as links to other drug information resources. The NCI Thesaurus also contains information on more than 3,000 other cancer-related drugs and agents. The Thesaurus is developed and maintained by NCI Enterprise Vocabulary Services, a joint effort by NCI's Office of Communications and Center for Bioinformatics to help meet the terminology needs of NCI and its partners.

< Previous Section


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov